<!DOCTYPE html>
<html>
<head>
<title>Catheter Ablation for AF</title>
<!-- Global site tag (gtag.js) - Google Analytics -->
<script async src="https://www.googletagmanager.com/gtag/js?id=UA-119340815-7"></script>
<script>
  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag('js', new Date());

  gtag('config', 'UA-119340815-7');
</script>

</head>
<meta charset="UTF-8">
<title>SCD Guidelines Review 2022 by heartRhythmBox.com</title>
<link rel="icon" href="box coral.png" type="image/png" sizes="60x60">
<meta name="viewport" content="width=device-width, initial-scale=1">
<meta name="author" content="t'Thon">
<link href="https://fonts.googleapis.com/css2?family=Playfair+Display:ital@1&family=Abel&display=swap" rel="stylesheet">
<script src="https://kit.fontawesome.com/2c3e1e841c.js" crossorigin="anonymous"></script>

<!--auto-ad-->
<script data-ad-client="ca-pub-1548733331544768" async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>

<!-- Global site tag (gtag.js) - Google Analytics -->
<script async src="https://www.googletagmanager.com/gtag/js?id=UA-119340815-1"></script>
<script>
  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag('js', new Date());

  gtag('config', 'UA-119340815-1');
</script>

<style>
*{margin: 0;padding: 0;box-sizing: border-box;
    font-family: 'Abel', sans-serif;
    pointer-events: all;  
}

/*fonts*/
.sans {font-family: 'Abel', sans-serif;}
.serif {font-family: 'Playfair Display', serif;}


*
{
  margin: 0;
  padding: 0;
  box-sizing: border-box;
  font-family: 'Abel', sans-serif;
}


.showcase
{
  position: fixed;
  right: 0;
  width: 100%;
  min-height: 100vh;
  padding: 3vmax;
  display: flex;
  align-items: center;
  background: #111;
  transition: 0.5s;
  z-index: 2;
}

.showcase video
{
  position: absolute;
  top: 0;
  left: 0;
  width: 100%;
  height: 100%;max-height: 100vh;
  object-fit: cover;
  opacity: 0.7;
}
.overlay
{
  position: absolute;
  top: 0;
  left: 0;
  width: 100%;
  height: 100%;
  background: #232323;
  mix-blend-mode: overlay;
}

.container {padding:0 ;position: relative;display: block;height: fit-content;z-index: 1;}
.endPage {text-align: center;font-size: 1.5vmax;padding: 2vmax;color: #797979;z-index: 1;}
.block {padding: 1vmax;}
.textBox {visibility: hidden;margin-top: 20vh;}
.imgBox {width: auto;height: auto;max-width:90%;;max-height: 70vh;visibility: hidden;object-fit:contain;
  padding: 3vmax;text-align: center;
  }

  @media only screen and (max-width: 800px) {
    .imgBox {width: 100%;max-width: 100%;}
  }


.ref {font-size: 1vmax;color: #96a9ae;padding-left: 1vmax;z-index: 10;cursor: pointer;position: relative;
line-height: 120%;margin-top: 0.5vh}
a {position: relative;z-index: 10;cursor: pointer;color:inherit;}


/*animation*/
.rotate {
  -webkit-transform:rotateX(30deg) perspective(3vh);
    -moz-transform:rotateX(30deg) perspective(3vh);
    -ms-transform:rotateX(30deg) perspective(3vh);
    -o-transform:rotateX(30deg) perspective(3vh);
    transform:rotateX(30deg) perspective(3vh);

    -webkit-transition:-webkit-transform 1.5s linear;
    -moz-transition:transform 1.5s ease-out;
    -o-transition:transform 1.5s ease-out;
    transition:transform 1.5s ease-out;
}

.offRotate{
  -webkit-transform:rotateX(0deg) perspective(0);
    -moz-transform:rotateX(0deg) perspective(0);
    -ms-transform:rotateX(0deg) perspective(0);
    -o-transform:rotateX(0deg) perspective(0);
    transform:rotateX(0deg) perspective(0);

    -webkit-transition:-webkit-transform 1.5s linear;
    -moz-transition:transform 1.5s ease-out;
    -o-transition:transform 1.5s ease-out;
    transition:transform 1.5s ease-out;
}

@keyframes rightIn {
  0% {transform:translateX(40vw);}
  100% {transform:translateX(0);}
}
@keyframes leftIn {
  0% {transform: translateX(-40vw);}
  100% {transform: translateX(0);}
}
@keyframes fadeOut{
  0% {opacity: 1;}
  100% {opacity: 0;}
}
@keyframes fadeIn{
  0% {opacity: 0;}
  100% {opacity: 1;}
}
@keyframes down{
   0% {height: 0;opacity: 0;}
   100% {height: fit-content;opacity: 1;}
}
@keyframes slideIn1 {
  0% {transform: translateX(-1vw);}
  40% {transform: translateX(-1vw);}
  90% {transform: translateX(0)}
  100% {transform: translateX(0);}
}

@keyframes slideIn2 {
  0% {transform: translateX(-1vw);}
  60% {transform: translateX(-1vw);}
  90% {transform: translateX(0);}
  100% {transform: translateX(0);}
}

@keyframes slideIn3 {
  0% {transform: translateX(-1vw);}
  80% {transform: translateX(-1vw);}
  95% {transform: translateX(0);}
  100% {transform: translateX(0);}
}

.rightIn {
  animation: rightIn 1s 1;
}
.leftIn {
  animation: leftIn 1s 1;
}
.fadeIn {
  animation: fadeIn 1s 1 ease-in;
}
.fadeOut {
  animation: fadeOut 1s 1 ease-out;
}
.blink {
  animation: fadeIn 0.5s 10 linear;
}




/*box*/
#scrollDown {display: none;z-index: 1;vertical-align: middle;font-size: 2vmax;
  animation: down 1s 5;color: white;padding: 0 1vmax;background: rgba(0,0,0,0.75);
}
.nav {display: none;color: #ddd;opacity: 0.9;font-size: 4vh;position: fixed;top: 35vh;left: 95vw;
  cursor: pointer;text-align: center;
}
.nav li :hover{color: #bbb;opacity: 0.98;}
.nav li{list-style-type: none;}
.flexBox1{display: flex;font-size: 2vmax;font-weight: 400;border: #fc553d solid 0.25vmax;margin: 1vmax 0;
  justify-content: center;align-content: center;align-items: center;
  padding: 0.5vmax;color: #f1f0e7;flex-wrap: wrap;line-height: 100%;
  }
.flexBox1 div {padding: 0.5vmax;line-height: 100%;justify-content: center;text-align: center;
  align-content: center;align-self: center;align-items: center;}

.L2R {width: 6%;align-content: center;align-items: center;text-align: center;font-size: 3vmax;padding: 0.5vmax;}
.arrow1 {color: #96a9ae;animation: slideIn1 2s infinite ease;}
.arrow2 {color: #96a9ae;animation: slideIn2 2s infinite ease;}
.arrow3 {color: #96a9ae;animation: slideIn3 2s infinite ease;}
.flexText20 {width: 20%;}
.flexText25 {width: 25%;}
@media only screen and (max-width: 800px) {
    .flexBox1 {border: none;border-bottom: #fc553d solid 0.25vh;}
    .flexText20, .flexText25 {width: 50%;border-bottom: #555 dotted 0.25vh;}
  }
@media screen and (max-width: 1200px) and (min-width: 801px){
  .flexBox1 {justify-content: flex-start;}
  .flexBox1 div {margin-top: 2vmax;text-align: left;line-height: 120%;}
  .flexText20 {width: 25%;padding:0.5vmax;}
  .L2R {width: 10%;padding: 0.5vmax;}
}

.flowXContainer, .flowXContainer2 {display: flex;overflow-x: scroll;flex-wrap: nowrap;
  justify-content:flex-start;text-align: left;}
.flowX, .flowX2 {margin: 0 0.3vmax;}
.xDot, .xDot2 {cursor: pointer;color: #aaa;font-size: 1.8vmax;}

/* Hide scrollbar for Chrome, Safari and Opera */
.hideScroll::-webkit-scrollbar {
  display: none;
}

/* Hide scrollbar for IE, Edge and Firefox */
.hideScroll {
  -ms-overflow-style: none;  /* IE and Edge */
  scrollbar-width: none;  /* Firefox */
}

.flowImg {width: auto;height: auto;max-height: 50vh;padding: 1vmax;}
.flowTxt {width: 100%;font-size: 1.8vmax;padding: 1vmax;color: white;line-height: 130%;}


</style>

<body>

<div class="showcase" onclick="scrollDown()">
  <div class="nav">
    <li><i class="fa-solid fa-angles-up" onclick="next(-2)" title="first"></i></li>
    <li><i class="fa-solid fa-angle-up" onclick="next(-1)" title ="before"></i></li>
    <li>|</li>
    <li><i class="fa-solid fa-angle-down" onclick="next(1)" title="next"></i></li>
    <li><i class="fa-solid fa-angles-down" onclick="next(2)" title="last"></i></li>
    <!--li id="test" style="color: blueviolet;">xx</li-->
  </div>
  <div id="toHide">
    <video src="media/green band BG.mp4" muted loop autoplay></video>
    <div class="overlay"></div>
 
    <div style="position: relative;z-index: 10;">
      <div style="font-weight: 800;font-size:5vmax;color: white;text-transform: uppercase;line-height: 100%;">
        Sudden Cardiac Death & Ventricular Arrhythmias  </div> 
      <div style="font-weight: 400;font-size: 2.5vmax;color: #f1f0e7;padding-top: 2vmax;
      text-transform: uppercase;line-height: 100%">
        2022 ESC Guidelines Review</div>
      <div class="serif" style="font-size:2.5vmax;color:#f1f0e7;">
        focus on CAD & DCM/HNDCM <br>
        <a href="https://doi.org/10.1093/eurheartj/ehac262" target="_blank" style="font-size:1.5vmax;color: #797979;">
          link to 2022 ESC Guidelines for SCD/VA
        </a>
      </div>
    </div>


    <ul style="position: absolute;bottom: 10vh;display: inline-block;display: flex;vertical-align: middle;
    justify-content: center;opacity: 0.75;">
      <li style="padding: 0.5vmax;"><a href="https://heartrhythmbox.com/" target="_blank"><img src="box transparent.png" style="width: 3vmax;"></a></li>
      <li style="padding: 0.5vmax;"><a href="https://www.facebook.com/HeartRhythmBox/" target="_blank"><img src="fb.png" style="width: 3vmax;"></a></li>
      <li id="scrollDown"><i class="fa-solid fa-angles-down"></i> Scroll down for more...</li>

    </ul>
    </div>
</div>

<!--LVEF NYHA 1-->
<div class="container">
    <div class="block" style="background-color: #232323;
    width: 100%;height: fit-content;">
        <div class="textBox" style="font-size: 6vmax;font-weight: 400;text-align: center;padding: 28vh 2vmax 2vmax 2vmax;
    z-index: 3;position: relative;text-align: left;line-height: 100%;">
        <div class="serif" style="border-left: #89f1ff 1vmax solid;padding-left: 1vmax;color: #f1f1f1;">
          LVEF & NYHA
          </div> 
          <div class="sans" style="font-size:2.5vmax;color: #aaa;">for SCD riks stratification</div>
        </div>
        <div class="textBox" 
        style="font-size: 2.5vmax;text-align: center;padding: 12vmax 5vmax 20vmax 5vmax;z-index: 1;
        text-align: center;line-height: 120%;color:#f1f0e7;">
            <span style="border-top: #89f1ff 1vh solid;font-weight: 600;">LVEF & NYHA</span> <br>
            remain the 2 key parameters for SCD risk stratifications.<br>
            LVEF & NYHA are strongly associated with SCD risks.<br>
            And treatment according to these 2 parameters reduce mortality. 
            See <a href="https://www.nejm.org/doi/full/10.1056/nejmoa013474" target="_blank">
            MADIT II</a> and
            <a href="https://www.nejm.org/doi/full/10.1056/nejmoa043399" target="_blank">
            SCD-HeFT</a> for examples.

        </div>
    </div>
</div>

<!--LVEF NYHA 2-->
<div class="container" style="background-color: #232323;">
<div class="block">
    <div class="textBox serif" style="font-size:5vmax;color:#fce3cb;padding: 2vmax;">
      Impaired LVEF after MI
        <div class="sans" style="font-size: 2.2vmax;color: #f1f1f1;padding-right: 20vw;
        line-height: 100%;font-weight: 400;">
        inversely correlates with risk of SCD. <br><br>
        ICD is recommended in post MI with LVEF &le;30%, after optimal medical treatment (OMT), regardless of symptoms.<br>
        </div>
    </div>
    
    <div style="text-align: left;padding: 2vmax;color: #f1f1f1;">
      <img src="Media/Valiant.jpg" class="imgBox" 
      style="padding: 0;">
      <br>
      <a href="https://www.nejm.org/doi/10.1056/NEJMoa043938" target="_blank" class="ref">
        VALIANT Trial NEJM 2005.</a>
    </div>
    <div class="textBox sans" style="font-size: 3vmax;text-align: right;
    padding:0.5vmax 1vmax;color: #b4e89c;margin-top: 5vh;line-height: 120%;">
      Majority of deaths in NYHA II & III are caused by SCD.
      <div style="color:#ddd;font-size:2vmax;line-height: 110%;">
      ICD is recommended in LVEF&le;35% and NYHA II or III with several underlying cardiac conditions.
      <div style="font-size:1.8vmax;color: #888;padding-left: 25vw;">
        Noted that the level of recommendation of ICD for DCM with LVEF&le;35% and NYHA II or III was downgraded from I to IIa 
      in response to the result of 
      <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1608029" target="_blank">
      DANISH trial.</a></div>
      </div>
    </div>
    <div style="text-align: right;padding: 2vmax;"> 
      <img src="media/NYHA.jpg" class="imgBox" style="padding: 0;"><br>
      <a href="https://doi.org/10.1016/S0140-6736(99)04440-2" target="_blank" class="ref">
        MERIT-HF. Lancet 1999.</a>
        
    </div>
    
</div>
</div>

<!--beyond LVEF & NYHA PES1-->
<div class="container" style="background-image: url('/SCD GL 2022/Media/roomWall.png');
background-position: top;background-repeat: no-repeat;background-size: contain;opacity: 0.8;
width: 100%;height: fit-content;background-color: #232323;">
  <div class="block">
     <div class="textBox serif" style="font-size:5vmax;color:#f1f1f1;padding: 2vmax;font-weight: 600;text-align: center;">
      BEYOND LVEF & NYHA
        <div class="sans" style="font-size: 2.2vmax;color: #eee;line-height: 120%;font-weight: 400;text-transform: uppercase;">
        &dot;Programmed Electrical Stimulation (PES)<br>
        &dot;Cardiac MRI<br>
        &dot;Genetic Testing<br>
        &dot;SCD Risk Score<br>
  </div>
</div>

    <div class="textBox sans" style="padding:0.5vmax 1vmax;color: #47dcda;margin-top: 20vh;
    line-height: 100%;font-size: 4vmax;font-weight: 700;">PES<br>
      <span style="font-weight: 400;color: #f1f0e7;font-size: 2.5vmax;text-align: justify;">
        is indicated in post MI patients with unexplained syncope who do not meet other criteria
      for ICD.
      <br>
      </span>
    </div>
    <div style="padding: 2vmax;padding-bottom: 20vh;">
      <img src="media/PESinMI.png" class="imgBox" style="padding: 0;">
    </div>
  </div>
</div>

<div class="container" style="background-image: url('/SCD GL 2022/Media/eps.png');
background-position: top;background-repeat: no-repeat;background-size: contain;opacity: 0.9;
width: 100%;height: fit-content;background-color: #111;margin-top: 0;padding:5vh 3vmax 20vh 3vmax;">
  <div class="textBox serif">
    <div style="font-size: 5vmax;color:#47dcda;font-weight: 700;
    line-height: 100%;text-align: center;">
    PES <span class="sans" style="font-size:2.5vmax">is useful in other conditions including...</span>
    </div>
    <div style="text-align: center;padding: 1vmax;">
    <span style="color:chartreuse;font-size:2.5vmax;font-weight: 500">
      &dot;Ischemic Cardiomyopathy, Neuromuscular Disease</span><br>
    <span style="color:yellow;font-size:2.5vmax;font-weight: 500">
      &dot;DCM/HNDCM, ARVC, Sarcoidosis, Congenital Heart Disease
    </span>  <br>
    <span style="color:coral;font-size:2.5vmax;font-weight: 500">
      &dot;Brugada Syndrome
    </span>  <br><br>
      <span class="ref" style="font-weight: 400;">
        color denotes class of recommendation. <br>
        <a href="https://doi.org/10.1093/eurheartj/ehac262" target="_blank">
          2022 ESC Guidelines for SCD/VA
        </a>
      </span>
    </div>
  </div>
</div>

<!--genetic-->
<div class="container" style="background: #1e1f2b;">
  <div class="block" style="padding: 8vmax 2vmax;">
    <div class="textBox" style="padding: 2vmax 0;">
        <div class="serif" style="font-size: 5vmax;color: #47dcda;font-weight: 700;">
        ETIOLOGIES OF DCM/HNDCM
        </div>
        <div class="san" style="font-size: 2.5vmax;color: white;line-height: 120%;">
        are widely variable among different population.
        
        <img src="media/hopkinsDCM.png" class="imgBox">
        <div class="ref" style="padding: 0;text-align: center;">
          <a href="https://doi.org/10.1056/nejm200004133421502" target="_blank">
            NEJM 2000</a>
        </div>
        <img src="media/ramaDCM.png" class="imgBox">
        <div class="ref" style="padding: 0;text-align: center;">
          <a href="https://he02.tci-thaijo.org/index.php/ramajournal/article/view/101903" target="_blank">
            Ramathibodi Medical Journal, 37(4), 176â€“182.</a>
        </div>
        </div>
    </div>


    <div class="textBox" style="padding: 2vmax;text-align: center;">
      <div class="san" style="font-size: 4vmax;font-weight: 700;color: #47dcda;line-height: 110%;">
        Genetic Mutation in DCM & SCD Risks
        <div class="san" style="font-size: 2vmax;color: #ddd;line-height: 100%;font-weight: 500;">
          Certain genetic mutations in DCM/HNDCM are associated with higher SCD risks.
        </div>
        <img src="media/genetic DCM.jpg" class="imgBox" style="padding-bottom: 0;width: 100%;">
      </div>
      <div class="ref">
        <a href="https://doi.org/10.1007/s00392-016-1033-6" target="_blank">
          Clin Res Cardiol. 2017.
        </a>
      </div>
    </div>

  </div>
</div>

<!--MRI-->
<div class="container">
  <div class="block" style="background-image: url('/SCD GL 2022/Media/MRI.png');
  background-position: bottom;background-repeat: no-repeat;background-size:contain;opacity: 0.9;
  width: 100%;height: fit-content;background-color: black;">
    <div class="textBox" style="padding: 3vmax 3vmax 0 3vmax;z-index: 3;position: relative;text-align: center;font-size: 6vmax;">
      <div class="serif" style="color: #47dcda;line-height: 120%;font-style: italic;font-size: 6vmax;">
        LGE in MRI and SCD Risks</div> 
        <img src="media/lgeDCM.png" class="imgBox">
      <a href="https://doi.org/10.1161/circulationaha.120.048477" target="_blank" class="ref">
        Circulation 2021.
      </a>
    </div>

    <div class="textBox" style="text-align: left;padding-bottom: 20vmax;padding-left: 2vmax;padding-right: 2vmax;">
      <div class="serif" style="font-size: 5vmax;color: #47dcda;font-weight: 700;line-height: 120%;">
      MRI in diagnosis and risk stratification
      </div>
      <div style="text-align: left;padding: 1vmax;">
        <span style="color:chartreuse;font-size:2.5vmax;font-weight: 500">
          &dot;Survivor of SCA w/o clear causes (after Echo), ARVC, HCM
        </span><br>
        <span style="color:yellow;font-size:2.5vmax;font-weight: 500">
          &dot;DCM/HNDCM, Suspected PVC-induced cardiomyopathy, LVNC, Neuromuscular Disease, Sarcoidosis
        </span>  <br>
        <span class="ref" style="font-weight: 400;">
            color denotes class of recommendation. 
            <a href="https://doi.org/10.1093/eurheartj/ehac262" target="_blank" style="padding-left: 1vmax">
              2022 ESC Guidelines for SCD/VA
            </a>
          </span>
        </div>
  </div>
</div>
</div>


<!--substrate abl-->
<div class="container">
  <div class="block" style="background-image: url('/afAblation/media/AF\ EGM.png');
  background-position: bottom;background-repeat: no-repeat;background-size: cover;
  width: 100%;height: fit-content;">
    <div class="textBox" style="padding: 8vmax 3vmax;z-index: 3;position: relative;text-align: center;font-size: 6vmax;">
      <div class="serif" style="color: #47dcda;line-height: 120%;font-style: italic;font-size: 6vmax;">
        SUBSTRATE ABLATION</div> 
      <div class="san" 
      style="color: white;line-height: 100%;font-weight: 600;font-size: 3vmax;padding-top: 2vmax;padding-bottom: 20vh;
      text-transform: uppercase;">
        Ablation strategy for persistent AF
      </div> 
    </div>
</div>
</div>

<!--Ps AF-->
<div class="container" style="background: #2d2d2d">
  <div class="block" style="padding: 8vmax 2vmax;">
    <div class="textBox" style="padding: 2vmax 0;text-align: left;">
        <div class="san" style="font-size: 5vmax;color: #47dcda;font-weight: 700;line-height: 120%;">
        COMPLEX FRACTIONATED EGM (CFAE)
        </div>
        
        <div class="san" style="font-size: 2vmax;color: #ddd;font-weight: 400;line-height: 120%;max-width: 90vw;">
        CFAEs correlate with areas of slowed conduction and pivot points of reentrant wavelets. 
        Results from the original trial showed that, in paroxysmal AF, 82% free of atrial arrhythmias in 1yr.
        In persistent AF, 70% free of atrial arrhythmias in 1yr.
        </div>
    </div>
        <img src="media/CAFE.png" class="imgBox" style="text-align: center;">
        <div class="ref">
          <a href="https://doi.org/10.1016/j.jacc.2003.12.054" target="_blank">JACC 2004.</a>
        </div>
  </div>

  <div class="textBox" style="padding: 2vmax 3vmax;text-align: right;">
    <div class="san" style="font-size: 5vmax;color: #47dcda;font-weight: 700;line-height: 120%;">
    ADDITIONAL LINE(S)
    </div>
    
    <div class="san" style="font-size: 2vmax;color: #ddd;font-weight: 400;line-height: 120%;">
      Linear ablations may be added along the left atrial roof, mitral isthmus, or box lesions connecting PV lesions.
    </div>
    <img src="media/PVILines.jpg" class="imgBox" style="text-align: right;">
    <div class="ref">
      <a href="https://doi.org/10.1056/nejmoa1408288" target="_blank">STAR-AF II. NEJM 2015.</a>
    </div>
    <img src="media/BoxLesion.jpg" class="imgBox" style="text-align:right">
    <div class="ref">
      <a href="https://doi.org/10.1016/j.jacc.2017.08.041" target="_blank">CAMERA-MRI. JACC 2017.</a>
    </div>
  </div>

  <div class="textBox" style="padding: 2vmax 0;text-align: center;">
    <div class="san" style="font-size: 5vmax;color: #47dcda;font-weight: 700;line-height: 120%;">
    IS PVI+ BETTER THAN PVI ALONE?
    </div>
    <div class="san" style="font-size: 2.5vmax;color: #ddd;font-weight: 600;line-height: 120%;">
    NOT REALLY.  
    </div>
    
    <img src="media/StarAFII.png" class="imgBox" style="text-align: center;">
    <div class="ref">
      <a href="https://doi.org/10.1056/nejmoa1408288" target="_blank">STAR-AF II. NEJM 2015.</a>
    </div>

  </div>

  <div class="textBox" style="padding: 12vmax 2vmax;word-wrap: break-word;">
    <span style="font-size: 4vmax;color:#47dcda;font-weight: 700;line-height: 130%;">
    OVERALL, ABLATION IMPROVE SYMPTOMS AND REDUCE AF RECURRENCE</span>
    <div class="san" 
    style="font-size: 2vmax;color: #f1f1f1;font-weight: 400;line-height: 100%;padding: 1vmax;">
      In CABANA (43% paroxysmal AF), catheter ablation was effective in reducing recurrence of any AF by 48% and symptomatic AF by 51% compared with drug therapy over 5 years of follow-up. 
    </div>
    <img src="media/CABANA sx and af recur.jpg" class="imgBox">
    <div class="ref">
      <a href="https://doi.org/10.1001/jama.2019.0693" target="_blank">CABANA Trial. JAMA 2019.</a>
    </div>
  </div>
</div>

  <div class="container greenL textBox" style="padding: 10vmax 3vmax;">
      <div class="serif" style="font-size: 5vmax;font-weight: 700;padding: 0 2vmax;line-height: 130%;color: #fc553d;word-wrap: break-word;">
      GUIDELINES RECOMMENDATIONS</div>
      <div class="sans" style="font-size: 3vmax;padding: 0 2vmax;color: #555;font-weight: 700;">
      FOR ABLATION TECHNIQUES
      </div>
      <div style="display: flex;flex-wrap: wrap;font-size: 3vmax;padding: 5vmax 1vmax;color: #343434;">
        <div style="background-color: lightgreen;padding: 1vmax;">
          <span style="font-size: 3.5vmax;font-weight: 700;">IA</span>
        complete isolation of PVs is recommended during all AF ablation.
        </div>
        <div style="background-color: coral;padding: 1vmax;">
          <span style="font-size: 3.5vmax;font-weight: 700;">IIB</span>
          using additional techniques beyond PVI may be considered but is not well established.
        </div>
      </div>
      <div class="ref">
        <a href="https://doi.org/10.1093/eurheartj/ehaa612" target="_blank">
          2020 ESC Guidelines for AF
        </a>
      </div>
  </div>

<div class="container greenD block" style="padding: 10vmax 2vmax;background-image: url('/afAblation/media/laRhythmia.png');
background-position: bottom;background-repeat: no-repeat;background-size: cover;
width: 100%;height: fit-content;">

  <div class="textBox" style="font-size: 5vmax;font-weight: 700;padding: 12vmax 2vmax;line-height: 130%;color: #f5f5f5;word-wrap: break-word;">
    ABLATION TO IMPROVE HARD OUTCOMES</div>
  

  <div class="textBox" style="font-size: 5vmax;font-weight: 700;padding: 1vmax 2vmax 0 2vmax;
  line-height: 100%;color: #eee;word-wrap: break-word;">
    <span style="border-top: solid 1vmax #fc553d;">HF</span>rEF
    <div class="san" style="font-size: 2vmax;color: #f1f1f1;font-weight: 400;line-height: 100%;padding: 1vmax 0;">
    In CASTLE-AF, catheter ablation reduced death and HF hospitalization in AF with HFrEF.
    </div>
  </div>
  <img src="media/castleAF AF 1endpoint.png" class="imgBox">
  <div class="ref">
    <a href="https://doi.org/10.1056/nejmoa1707855" target="_blank">CASTLE-AF. NEJM 2018.</a>
  </div>

  <div class="textBox" style="font-size: 5vmax;font-weight: 700;padding: 10vmax 2vmax 0 2vmax;
  line-height: 100%;color: #eee;word-wrap: break-word;">
    <span style="border-top: solid 1vmax #fc553d;">Symp</span>tomatic Paroxysmal or Persistent AF

  <div class="san" 
  style="font-size: 2vmax;color: #f1f1f1;font-weight: 400;line-height: 100%;padding: 2vmax 0;">
    In CABANA-AF, catheter ablation reduced primary outcomes (death, stroke, cardiac arrest, and serious bleeding) only in per-protocol analysis but not in ITT.
    Of note, 27.5% crossed-over from drugs to ablation group.
  </div>
  </div>
  <img src="media/CABANA perP.png" class="imgBox" style="filter: invert();">
  <div class="ref">
    <a href="https://doi.org/10.1001/jama.2019.0693" target="_blank">CABANA Trial. JAMA 2019.</a>
  </div>

  <div class="san textBox" 
  style="font-size: 3vmax;color: white;font-weight: 700;line-height: 100%;padding: 10vmax 2vmax 0 2vmax;text-align: center;">
    In a systematic review and meta-analysis, mortality benefit of catheter ablation is mainly driven by AF with HFrEF patients.

    <img src="media/metaAna.jpg" class="imgBox" style="text-align: center;width: 100%;max-height: 85vh;padding:2vmax 0.5vmax;">
    <div class="ref" style="text-align: center;font-weight: 400;">
      <a href="https://doi.org/10.1161/CIRCEP.119.007414" target="_blank">Circulation: Arrhythmia and Electrophysiology. 2019</a>
    </div>
  </div>
</div>

<div class="container greenL textBox" style="padding: 10vmax 3vmax;text-align: center;">
  <div class="serif" style="font-size: 5vmax;font-weight: 700;padding: 0 2vmax;line-height: 130%;color: #fc553d;word-wrap: break-word;">
  GUIDELINES RECOMMENDATIONS</div>
  <div class="sans" style="font-size: 3vmax;padding: 0 2vmax;color: #555;font-weight: 700;">
  INDICATIONS FOR CATHETER ABLATION OF AF<br>
  </div>
  <img src="media/escGL2020.jpeg" class="imgBox">
  
  
  <div class="flowXContainer" 
  style="font-size: 2vmax;color: #343434;">
    <div class="flowX" style="background-color: lightgreen;padding: 1vmax;">
      <span style="font-size: 2.5vmax;font-weight: 700;">IA</span><br>
    2nd line (after failed AAD) | symptomatic AF of any types.
    </div>
    <div class="flowX" style="background-color: lightgreen;padding: 1vmax;">
      <span style="font-size: 2.5vmax;font-weight: 700;">IA</span><br>
    1st line | HFrEF (when tachycardiomyopathy is highly probable).
    </div>
    <div class="flowX" style="background-color: yellow;padding: 1vmax;">
      <span style="font-size: 2.5vmax;font-weight: 700;">IIA</span><br>
    2nd line (after failed AAD) | HFrEF; to improve survival.
    </div>
    <div class="flowX" style="background-color: yellow;padding: 1vmax;">
      <span style="font-size: 2.5vmax;font-weight: 700;">IIA</span><br>
      1st line | symptomatic paroxysmal AF
    </div>
    <div class="flowX" style="background-color: coral;padding: 1vmax;">
      <span style="font-size: 2.5vmax;font-weight: 700;">IIB</span><br>
      1st line | symptomatic persistent AF
    </div>
  </div>

  <div class="ref" style="text-align: left;">
    <a href="https://doi.org/10.1093/eurheartj/ehaa612" target="_blank">
      2020 ESC Guidelines for AF
    </a>
  </div>
  <!--div class="dotRow" style="text-align: center;">
    <span class="xDot" onclick="navX(0)"><i class="fa-solid fa-circle"></i></span>
    <span class="xDot" onclick="navX(1)"><i class="fa-solid fa-circle"></i></span>
    <span class="xDot" onclick="navX(2)"><i class="fa-solid fa-circle"></i></span>
    <span class="xDot" onclick="navX(3)"><i class="fa-solid fa-circle"></i></span>
    <span class="xDot" onclick="navX(4)"><i class="fa-solid fa-circle"></i></span>
  </div-->

</div>

<!--complicaiton-->
<div class="container">
  <div class="block" style="background-image: url('/afAblation/media/AF\ EGM.png');
  background-position: bottom;background-repeat: no-repeat;background-size: cover;
  width: 100%;height: fit-content;">
    <div class="textBox" style="padding: 8vmax 3vmax;z-index: 3;position: relative;text-align: left;font-size: 6vmax;">
      <div class="serif" style="color: #47dcda;line-height: 120%;font-style: italic;font-size: 6vmax;word-wrap: break-word;">
        COMPLICATIONS</div> 
      <ul class="san" 
      style="color: white;line-height: 120%;font-weight: 400;font-size: 3vmax;padding-top: 2vmax;padding-bottom: 20vh;padding-left: 2vmax;
      text-transform:capitalize;">
        <li>&lt;0.1%: Periprocedural Death</li>
        <li>1%: Major Complications (i.e. tamponade, AE fistula, and stroke)</li>
        <li>5%: Moderate Complications (i.e. PV stenosis, phrenic nerve injury, and vascular complication)</li>
      </ul> 
    </div>
    <div class="ref" style="text-align: left;">
      <a href="https://doi.org/10.1093/eurheartj/ehaa612" target="_blank">
        2020 ESC Guidelines for AF
      </a>
    </div>
</div>
</div>

<!--specific complications-->
<div class="container textBox" style="background-color: #2d2d2d;padding-bottom: 5vmax;">
  <div class="serif" style="color: #47dcda;line-height: 120%;font-style: italic;font-size: 5vmax;
  padding: 3vmax;text-align: center;word-wrap: break-word;">
    SPECIFIC COMPLICATIONS</div> 
  <div class="flowXContainer2" 
  style="padding: 2.5vmax;">
    <!--1.AEF-->
    <div class="flowX2" style="border-right: #47dcda solid 1vmax;">
      <img src="media/AE fistula sum.png" class="flowImg">

      <div class="flowTxt">
        <span style="font-size: 2vmax;color: #47dcda;text-align: center;font-weight: 800;text-transform: uppercase;">1. Atrio-esophageal fistula
        </span><br>
        <ul style="padding-left: 1vmax;">
          <li>Lethal</li>
          <li>Require prompt confirmation and intervention</li>
        </ul>
      </div>
    </div>


    <!--2. PV stenosis-->
    <div class="flowX2" style="border-right: #47dcda solid 1vmax;">
      <img src="media/pvIntervention.jpg" class="flowImg">
      <div class="flowTxt" style="padding: 1vmax;">
        <span style="font-size: 2vmax;color: #47dcda;text-align: center;font-weight: 800;
        text-transform: uppercase;">2. Pulmonary Vein Stenosis
        </span><br>
        <ul style="padding-left:1vmax;">
          <li>Severe stenosis (>75%) is uncommon with the current technology (&lt;1%).</li>
          <li>Symptoms: occur in 3-6mos, including dyspnea & recurrent pneumonia.</li>
        </ul>
      </div>
    </div>

    <!--3. phrenic-->
    <div class="flowX2" style="border-right: #47dcda solid 1vmax;">
      <img src="media/Phrenic nerve.jpg" class="flowImg">
      <div class="flowTxt" style="padding: 1vmax;">
        <span style="font-size: 2vmax;color: #47dcda;text-align: center;font-weight: 800;
        text-transform: uppercase;">3. Phrenic Nerve Injury
        </span><br>
        <ul style="padding-left:1vmax;">
          <li>More common in cryoballoon than RF.</li>
          <li>Mostly transient & spontaneous recover in 6-12mos.</li>
        </ul>
      </div>
    </div>

    <!--4. vagus-->
    <div class="flowX2">
      <img src="media/gastroparesis.png" class="flowImg">
      <div class="flowTxt" style="padding: 1vmax;">
        <span style="font-size: 2vmax;color: #47dcda;text-align: center;font-weight: 800;
        text-transform: uppercase;">4. Gastroparesis
        </span><br>
        <ul style="padding-left:1vmax;">
          <li>From vagal denervation.</li>
          <li>Mostly transient & asymptomatic.</li>
        </ul>
      </div>
    </div>
    
  </div>

  <!--div class="dotRow2" style="text-align: center;">
    <span class="xDot2" onclick="navX2(0)"><i class="fa-solid fa-circle"></i></span>
    <span class="xDot2" onclick="navX2(1)"><i class="fa-solid fa-circle"></i></span>
    <span class="xDot2" onclick="navX2(2)"><i class="fa-solid fa-circle"></i></span>
    <span class="xDot2" onclick="navX2(3)"><i class="fa-solid fa-circle"></i></span>
  </div-->

  <div class="ref" style="text-align: center;padding-top: 2.5vmax;">
    Ref:
    <a href="https://doi.org/10.1016/j.hrthm.2017.05.012" target="_blank">
      2017 HRS Guidelines for AF Ablation
    </a>,
    <a href="https://doi.org/10.1161/CIRCEP.117.006001" target="_blank">
      Circulation: Arrhythmia and Electrophysiology. 2018
    </a>, <a href="https://doi.org/10.1016/j.hrthm.2014.01.010" target="_blank">
      Heart Rhythm 2014.
    </a>, and
    <a href="https://doi.org/10.1161/CIRCEP.113.001329" target="_blank">
      Circulation: Arrhythmia and Electrophysiology. 2014.
    </a>
  </div>

</div>

<!--periOp-->
<div class="container">
  <div class="block" style="background-image: url('/afAblation/media/rhythmia2.png');
  background-position: bottom;background-repeat: no-repeat;background-size: cover;
  width: 100%;height: fit-content;">
    <div class="serif textBox" style="color: white;line-height: 120%;font-style: italic;font-size: 5vmax;
    padding: 3vmax;text-align: center;word-wrap: break-word;">
      PERI-PROCEDURAL STROKE RISK MANAGEMENT 
    <img src="media/periOpOAC.png" class="imgBox" style="text-align: center;">
    <div class="ref">
      <a href="https://doi.org/10.1093/eurheartj/ehz190" target="_blank">Eur Heart J 2019</a>
    </div>
    </div>
    <div class="flowXContainer textBox" 
    style="padding: 2.5vmax;justify-content:space-between;margin-top: 10vh;align-content: center;">
      <div class="flowX" style="color: white;font-size: 2vmax;border-right: #47dcda 0.5vmax solid;padding: 1VMAX;">
       <span style="font-size: 2.5vmax;text-transform: uppercase;font-weight: 700;color: #47dcda;">Before Ablation</span>
      <br>OAC at least <b>3wks</b> or TEE before ablation
      </div>
      <div class="flowX" style="color: white;font-size: 2vmax;border-right: #47dcda 0.5vmax solid;padding: 1vmax;">
        <span style="font-size: 2.5vmax;text-transform: uppercase;font-weight: 700;color: #47dcda;">Right Before Ablation</span>
       <br> No OAC Interruption
      </div>
      <div class="flowX" style="color: white;font-size: 2vmax;padding: 1vmax;">
        <span style="font-size: 2.5vmax;text-transform: uppercase;font-weight: 700;color: #47dcda;">After Ablation</span><br>
        At least <b>2 months</b> of OAC.<br> Long-term OAC: based on stroke risk profile <b style="color: #fc553d;">not the result of the ablation.</b>
      </div>
      
    </div>
    <div class="ref" style="text-align: left;">
      <a href="https://doi.org/10.1093/eurheartj/ehaa612" target="_blank">
        2020 ESC Guidelines for AF
      </a>
    </div>

  </div>
</div>

<!--recur-->
<div class="container greenL">
  <div class="block" style="text-align: center;">
    <div class="textBox" style="color: #fc553d;line-height: 120%;font-size: 5vmax;font-weight: 700;
    padding: 12vmax 5vmax;text-align: center;">
      WHY AF RECURS AFTER ABLATION?
    </div>

    <div class="textBox" style="font-size: 4vmax;font-weight: 700;text-transform: sentence;
    padding: 5vmax 2vmax 0 2vmax;color: #797979;">
      Because of the reconnected PV(s)
    </div>

    <img src="media/pvReconnect.jpg" class="imgBox">
    <div class="ref">
      <a href="https://doi.org/10.1161/CIRCEP.119.007247" target="_blank">
        Circulation: Arrhythmia and Electrophysiology. 2019.
      </a>
    </div>

    <div class="textBox" style="font-size: 4vmax;font-weight: 700;text-transform: sentence;
    padding: 5vmax 2vmax 0 2vmax;color: #797979;">
      Because of non-PV trigger(s)
    </div>

    <img src="media/nonPV.png" class="imgBox">
    <div class="ref">
      <a href="https://doi.org/10.1016/j.hrthm.2017.02.030" target="_blank">
        Heart Rhythm 2017.
      </a>
    </div>

    <div class="textBox" style="font-size: 4vmax;font-weight: 700;text-transform: sentence;
    padding: 5vmax 2vmax 0 2vmax;color: #797979;text-align: center;">
      And because of the patient's factors.
    </div>

    <img src="media/risk score after abl.png" class="imgBox">
    <div class="ref">
      <a href="https://doi.org/10.1093/eurheartj/ehaa612" target="_blank">
        2020 ESC Guidelines for AF
      </a>
    </div>


  </div>

</div>

<!--conclusions-->
<div class="container" style="background: #1e1f2b;">
  <div class="block" style="padding: 8vmax 2vmax;">
    <div class="textBox" style="padding: 2vmax 0;text-align: center;">
        <div class="san" style="font-size: 5vmax;color: #47dcda;font-weight: 700;line-height: 120%;">
        CONCLUSIONS
        </div>

    <ul style="color: white;font-size: 2.5vmax;padding: 2vmax;max-width: 1000px;text-align: justify;
    margin-left: auto;margin-right: auto;">
        <li>AF Ablation improves symptoms, reduces recurrence atrial 
          arrhythmias, and improve mortality in selected group of patients.</li>
        <li>AF Ablation is a <span class="serif" style="font-weight: 700;">'SAVAGE'</span> therapy after failed AAD.</li>
        <li>AF Ablation is now a <span class="serif" style="font-weight: 700;">'STANDARD'</span> therapy in AF with HFrEF or symptomatic paroxysmal AF.</li>
        <li>Though AF Ablation is a relatively safe procedure, complications do occur.</li>
    </ul>
    </div>

  </div>
</div>


<!--end page-->
<div class="skyLight endPage" style="padding: 3vmax;">
  <a href="#top" style="font-size:1.5vmax;text-decoration: none;" title="to top">
    <i class="fa-solid fa-circle-chevron-up" style="font-size: 2vmax;"></i> to top</a><br>
    
    <span class="serif" style="color: #777777;font-weight: 700;">HeartRhythmBox</span>, an education page of heart rhythm topics.<br>
    visit us at <a href="https://heartrhythmbox.com" target="_blank">
      <img src="box coral.png" style="width: 2.2vmax;padding-right: 4px;">www.heartrhythmbox.com</a><br>
    or <a href="https://www.facebook.com/HeartRhythmBox/" target="_blank">https://www.facebook.com/HeartRhythmBox/</a>
</div>

</body>

<script>

//nav

var bNo = 0;  
box = document.getElementsByClassName('textBox')


function next(no){
  n = Number(no);
  //check which box is in the view
  var i;
  for (i=0;i<box.length;i++){
    var top = box[i].getBoundingClientRect().top;
    if (top<window.innerHeight/2){
      bNo=i;
    }
  }

  if (n==-2) {
    window.scrollTo(0,0);bNo=0;
    }
  if (n==2){
    last = box.length-1;
    box[last].scrollIntoView({behavior:"smooth", block:"start"});
    bNo=last
  }

  if (n==1 || n==-1){
      bNo = n + bNo;
      if (bNo<0){
        window.scrollTo(0,0);bNo=-1;
      }
      if (bNo>=box.length){
        var end = document.getElementsByClassName('endPage')
        end[0].scrollIntoView({behavior:"smooth", block:"start"})
        bNo=box.length+1;
      }
    
      box[bNo].scrollIntoView({behavior:"smooth", block:"start"});
  }
} 

function flowX(x){
  n = Number(x);
  xNo = n + xNo;flowX[xNo].scrollIntoView({behavior:"smooth", block:"start"})
  if (xNo<0){
    xNo=0;flowX[xNo].scrollIntoView({behavior:"smooth", block:"start"})
  }
  else {flowX[xNo].scrollIntoView({behavior:"smooth", block:"start"})
  }
}
  

window.onscroll = function(){
    
    //hide intro
    sCase = document.getElementsByClassName('showcase');
    document.getElementById('toHide').style.display = 'none'
    sCase[0].style.top = '90vh'
    sCase[0].style.background ='none'
    nav = document.getElementsByClassName('nav')
    if (window.matchMedia("(max-width: 1024px)").matches) {
      nav[0].style.display = 'none';
    } else {
      nav[0].style.display = 'block';
    } 

    document.getElementById('scrollDown').style.display='none'
    
    //scroll content into view
    container = document.getElementsByClassName('container');
    block = document.getElementsByClassName('block')
    
    container[0].style.transform = 'translateY(15vh)'
    container[0].style.transitionDuration = '1s'

    //scrollUp to show intro
    var top = container[0].getBoundingClientRect().top;
    if (window.scrollY<=15*window.innerHeight && top>0){
        container[0].style.transform = 'translateY(0)'
        sCase[0].style.top = '0'
        document.getElementById('toHide').style.display ='block'
        sCase[0].style.backgroundColor ='black'
        nav[0].style.display = 'none'
    }

    //animateTextBox
    txtB = document.getElementsByClassName('textBox')
    var i;
    for (i=0;i<txtB.length;i++){
        var top = txtB[i].getBoundingClientRect().top;
        if (top>0.25*window.innerHeight){

            txtB[i].style.visibility = 'hidden'
            txtB[i].classList.add('fadeOut')
            txtB[i].classList.remove('fadeIn')
          }  else  
        { txtB[i].classList.remove('fadeOut')
          txtB[i].classList.add('fadeIn')
          txtB[i].style.visibility = 'visible'
        }
    }



    //animateImgBox
    imgBox = document.getElementsByClassName('imgBox')
    var j;
    for (j=0;j<imgBox.length;j++){
      var top = imgBox[j].getBoundingClientRect().top;
          if (top>0.4*window.innerHeight){
          imgBox[j].classList.remove('fadeIn')
          imgBox[j].classList.add('fadeOut')
          imgBox[j].style.visibility = 'hidden'
          

       } else
        { imgBox[j].classList.add('fadeIn')
          imgBox[j].classList.remove('fadeOut')
          imgBox[j].style.visibility = 'visible'
        }
    }
    //remove unnecessary scrollX dot
    checkDot();
}  

function scrollDown(){
  document.getElementById('scrollDown').style.display= 'block'
}
function toTop(){
  window.scrollTo(0,0)
}

function checkDot(){
  var container = document.getElementsByClassName('flowXContainer')
  var dot = document.getElementsByClassName('dotRow')
  var i;
  for (i=0;i<container.length;i++){
    if (container[i].clientWidth>=container[i].scrollWidth){
      dot[i].style.display = 'none'
      container[i].classList.add('hideScroll')
    } else {
      dot[i].style.display = 'block'
      container[i].classList.remove('hideScroll')
    }
  }  
}

function navX(x){
  var flowX = document.getElementsByClassName('flowX')
  var dot = document.getElementsByClassName('xDot')
  var container = document.getElementsByClassName('flowXContainer')

  //clear dot color 797979 232323
  var i;
  for (i=0;i<dot.length;i++){
    dot[i].style.color = '#797979'
  }
  dot[x].style.color = '#232323'

  //get Y position
  var leftPos = flowX[x].getBoundingClientRect().left;
  var topPos = flowX[x].getBoundingClientRect().top;
  var cLeft = container[0].getBoundingClientRect().left;
  var scrollPos = container[0].scrollLeft;
  var toLeft = leftPos-scrollPos;
  container[0].scrollTo(toLeft,0)
}

function navX2(x){
  var flowX = document.getElementsByClassName('flowX2')
  var dot = document.getElementsByClassName('xDot2')
  var container = document.getElementsByClassName('flowXContainer2')

  //clear dot color 797979 232323
  var i;
  for (i=0;i<dot.length;i++){
    dot[i].style.color = '#dddddd'
  }
  dot[x].style.color = '#797979'

  //get Y position
  var leftPos = flowX[x].getBoundingClientRect().left;
  var topPos = flowX[x].getBoundingClientRect().top;
  var cLeft = container[0].getBoundingClientRect().left;
  var scrollPos = container[0].scrollLeft;
  var toLeft = leftPos-scrollPos;
  document.getElementById('test').innerHTML = 'leftPos' + leftPos + ' scrollPos' + scrollPos;
  container[0].scrollTo(leftPos,0)
}

</script>

</html>